On which day after chemotherapy does the nadir of blood counts typically occur?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Nadir Timing After Chemotherapy

The nadir of blood counts typically occurs between days 7-14 after chemotherapy, with the absolute neutrophil count (ANC) nadir most commonly occurring around days 10-14, and the monocyte nadir appearing earlier around day 6.

Timing of Nadir by Cell Type

The nadir timing varies by cell lineage:

  • Neutrophil nadir: Typically occurs around day 10-14 after chemotherapy initiation 1
  • Monocyte nadir: Occurs earlier at approximately day 6, preceding the neutrophil nadir by about 6 days 2
  • Platelet recovery: Partial recovery typically begins around day 18, with complete recovery by day 25 3

Clinical Implications for Growth Factor Timing

The NCCN guidelines explicitly address this nadir period when recommending timing of myeloid growth factors 4, 5:

  • Filgrastim/tbo-filgrastim: Start 24-72 hours (1-3 days) after chemotherapy completion and continue through post-nadir recovery until ANC returns to normal or near-normal levels
  • Pegfilgrastim: Single dose administered 24-72 hours after chemotherapy (category 1 recommendation for next-day administration)
  • Growth factors should never be given on the same day as chemotherapy due to increased risk of febrile neutropenia

The Critical "Nadir Period"

Days 7-14 post-chemotherapy represent the highest-risk period for neutropenia and infection 6. This window is when:

  • Neutrophil counts reach their lowest point
  • Risk of febrile neutropenia peaks
  • Patients are most vulnerable to serious infections
  • Intramuscular injections or invasive procedures should be avoided when possible

Monitoring Strategy

Based on the evidence, monocyte counts can serve as an early predictor of neutrophil nadir 2:

  • An absolute monocyte count (AMC) nadir of ≤100/μL predicts an ANC nadir <1000/μL with 83% sensitivity
  • Monitoring monocyte trends around day 6 can help anticipate the neutrophil nadir timing around day 12

Regimen-Specific Variations

The specific nadir timing can vary based on:

  • Chemotherapy intensity: More intensive regimens may produce earlier or more prolonged nadirs
  • Patient factors: Age ≥65 years, prior chemotherapy, baseline neutropenia, or bone marrow involvement can affect nadir depth and duration 4
  • Specific agents: Different chemotherapy regimens have characteristic nadir patterns

Key clinical pearl: The depth of the nadir inversely correlates with recovery duration—deeper nadirs take longer to recover 1. However, contrary to older assumptions, a short duration of aplasia does not necessarily indicate poor therapeutic efficacy 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.